These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 3318455

  • 1. Fenofibrate affects the compositions of lipoproteins.
    Goldberg AC, Schonfeld G, Anderson C, Dillingham MA.
    Am J Med; 1987 Nov 27; 83(5B):60-5. PubMed ID: 3318455
    [Abstract] [Full Text] [Related]

  • 2. Effect of fenofibrate treatment on plasma lipoprotein lipids, high-density lipoprotein cholesterol subfractions, and apolipoproteins B, AI, AII, and E.
    Knopp RH, Walden CE, Warnick GR, Albers JJ, Ginsberg J, McGinnis BM.
    Am J Med; 1987 Nov 27; 83(5B):75-84. PubMed ID: 3120587
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Multicenter comparison of micronized fenofibrate and simvastatin in patients with primary type IIA or IIB hyperlipoproteinemia.
    Steinmetz A, Schwartz T, Hehnke U, Kaffarnik H.
    J Cardiovasc Pharmacol; 1996 Apr 27; 27(4):563-70. PubMed ID: 8847874
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Low-dose colestipol plus fenofibrate: effects on plasma lipoproteins, lecithin:cholesterol acyltransferase, and postheparin lipases in familial hypercholesterolemia.
    Weisweiler P.
    Metabolism; 1989 Mar 27; 38(3):271-4. PubMed ID: 2918846
    [Abstract] [Full Text] [Related]

  • 13. Potential use of fenofibrate and other fibric acid derivatives in the clinic.
    Brown WV.
    Am J Med; 1987 Nov 27; 83(5B):85-9. PubMed ID: 3688012
    [Abstract] [Full Text] [Related]

  • 14. Lipoprotein composition changes induced by fenofibrate in dysbetalipoproteinemia type III.
    Lussier-Cacan S, Bard JM, Boulet L, Nestruck AC, Grothé AM, Fruchart JC, Davignon J.
    Atherosclerosis; 1989 Aug 27; 78(2-3):167-82. PubMed ID: 2783201
    [Abstract] [Full Text] [Related]

  • 15. Free fatty acid metabolism during fenofibrate treatment of the metabolic syndrome.
    Vega GL, Cater NB, Hadizadeh DR, Meguro S, Grundy SM.
    Clin Pharmacol Ther; 2003 Sep 27; 74(3):236-44. PubMed ID: 12966367
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effects of fenofibrate on plasma lipids. Double-blind, multicenter study in patients with type IIA or IIB hyperlipidemia.
    Brown WV, Dujovne CA, Farquhar JW, Feldman EB, Grundy SM, Knopp RH, Lasser NL, Mellies MJ, Palmer RH, Samuel P.
    Arteriosclerosis; 1986 Sep 27; 6(6):670-8. PubMed ID: 3535757
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.